KL-ON113

N/A

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameKL-ON113
Drug Alias NameKL-ON113
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKasina Laila Innova Pharmaceuticals Private Limited
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKasina Laila Innova Pharmaceuticals Private Limited
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A